PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
24-Feb-2026 Schrödinger to Participate in Upcoming Investor Conferences Businesswire
24-Feb-2026 Regentis Biomaterials Reports 2025 Financial Results and Provides Business Update ACCESS Newswire
24-Feb-2026 Advanced Health Alliance Sponsors Undefeated Professional Boxer Shea Willcox in Sixth Pro Victory ACCESS Newswire
24-Feb-2026 BostonGene CEO Andrew Feinberg to Deliver Keynote at Mobile World Congress Barcelona 2026 Businesswire
24-Feb-2026 XiFin Reports Double-Digit Segment Growth and 21.1% Increase in Empower RCM Volume; Names New CTO to Accelerate AI Strategy Businesswire
24-Feb-2026 Thermo Fisher Scientific to Present at Raymond James Annual Institutional Investors Conference Businesswire
24-Feb-2026 Vico Therapeutics Announces Patient Dosing in Twice-Annual Regimen of VO659 in Phase 1/2 Trial in Huntington’s Disease, Spinocerebellar Ataxia Type 3 and Type 1 Businesswire
24-Feb-2026 OmniAb to Participate at the Leerink Partners Global Healthcare Conference Businesswire
24-Feb-2026 Jaguar Gene Therapy Announces Successful Completion of Dosing of First Patient Cohort in Clinical Trial Evaluating JAG201 for the Treatment of a Leading Monogenic Cause of Autism Spectrum Disorder Known as Phelan-McDermid Syndrome Businesswire
24-Feb-2026 Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitis Sanofi, Regeneron
24-Feb-2026 NICE Recommends TEPKINLY®▼ (epcoritamab), a Subcutaneous Bispecific Antibody for Adults With Relapsed/Refractory (R/R) Follicular Lymphoma (FL) After Two or More Lines of Systemic Therapy Abbvie
24-Feb-2026 Slate Medicines Launches with $130 Million Series A Financing to Advance Anti-PACAP Therapies for the Prevention of Migraine and Other Headache Disorders Businesswire
24-Feb-2026 Harmony Biosciences Reports Strong 2025 Financial Results and Reiterates 2026 Net Revenue Guidance of Over $1 Billion Businesswire
24-Feb-2026 Cartography Biosciences Doses First Patient in Phase 1 Trial of CBI-1214, a Highly Specific T-Cell Engager for the Treatment of Colorectal Cancer Businesswire
24-Feb-2026 Starlab Space Announces LambdaVision as Latest Customer for its On-Orbit Science Park Businesswire
24-Feb-2026 TRNR Wins Decisively in Berlin Court Against Sportstech's Claims ACCESS Newswire
24-Feb-2026 LUMANITY LAUNCHES EMULAITOR™, AN AI-POWERED SYNTHETIC PERSONA PLATFORM TRANSFORMING STAKEHOLDER ENGAGEMENT IN LIFE SCIENCES LUMANITY
24-Feb-2026 Ideagen Earns G2 2026 Best Software Awards for Third Consecutive Year Businesswire
24-Feb-2026 AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2025 Results and Provides 2026 Financial Guidance Businesswire
24-Feb-2026 Satellos Announces Upcoming Oral and Poster Presentations at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference Businesswire